MPLT stock

MapLight Therapeutics, Inc. Common Stock (MPLT) financials · $1.24B cap

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

MapLight Therapeutics, Inc. Common Stock (MPLT) $1.24B cap.

Cached annual income statement
LineFY2025FY2024
Operating Income-$169.1M-$82.9M
Net Income-$161.2M-$77.6M
Cached annual balance sheet
LineFY2025
Total Assets$479.5M
Current Assets$324.7M
Cash & Equivalents$46.7M
PP&E$1.09M
Total Liabilities$21.1M
Current Liabilities$16.2M
Shareholders' Equity$458.4M
Retained Earnings-$360.5M
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$138.1M-$78.8M
CapEx$473.0K$770.0K
Investing Cash Flow-$323.2M-$80.8M
Financing Cash Flow$469.8M$118.1M
Free Cash Flow-$138.6M-$79.6M
These statements as JSON? API free 100/day

FAQ

What is MPLT P/E and revenue?

MapLight Therapeutics, Inc. Common Stock (MPLT) $1.24B cap.

What is MPLT revenue?

MPLT income-statement cache has no revenue figure yet.

Is MPLT profitable?

MapLight Therapeutics, Inc. Common Stock last cached net income is -$161.2M (FY2025).

What are MPLT total assets?

MapLight Therapeutics, Inc. Common Stock last cached total assets are $479.5M (FY2025).

What is MPLT free cash flow?

MapLight Therapeutics, Inc. Common Stock last cached free cash flow is -$138.6M (FY2025).

Not investment advice. Cached statements, not a live tape.